NOK 1.33
(-0.38%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 1000.00 NOK | 0.0% |
2022 | - NOK | -100.0% |
2021 | 938 Thousand NOK | 17.4% |
2020 | 799 Thousand NOK | -90.88% |
2019 | 8.76 Million NOK | 224.96% |
2018 | -7.01 Million NOK | 2.2% |
2017 | -7.17 Million NOK | 8.19% |
2016 | -7.81 Million NOK | -1137.18% |
2015 | 753 Thousand NOK | 0.0% |
2014 | - NOK | 0.0% |
2013 | - NOK | 0.0% |
2012 | - NOK | 0.0% |
2011 | - NOK | 0.0% |
2010 | - NOK | 0.0% |
2009 | - NOK | 0.0% |
2008 | - NOK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - NOK | 0.0% |
2024 Q1 | - NOK | 100.0% |
2023 Q1 | - NOK | 0.0% |
2023 Q3 | - NOK | 0.0% |
2023 Q2 | - NOK | 0.0% |
2023 FY | 1000.00 NOK | 0.0% |
2023 Q4 | -2.57 Million NOK | 0.0% |
2022 Q2 | -15.34 Million NOK | -1391.92% |
2022 Q4 | - NOK | 100.0% |
2022 Q3 | -1.73 Million NOK | 88.68% |
2022 Q1 | 1.18 Million NOK | 109.74% |
2022 FY | - NOK | -100.0% |
2021 Q2 | -15.25 Million NOK | -14.84% |
2021 Q1 | -13.28 Million NOK | -0.95% |
2021 Q4 | -12.2 Million NOK | -442.41% |
2021 Q3 | 3.56 Million NOK | 123.35% |
2021 FY | 938 Thousand NOK | 17.4% |
2020 Q4 | -13.16 Million NOK | 0.0% |
2020 Q1 | - NOK | 0.0% |
2020 Q2 | - NOK | 0.0% |
2020 Q3 | - NOK | 0.0% |
2020 FY | 799 Thousand NOK | -90.88% |
2019 Q1 | - NOK | 0.0% |
2019 Q2 | - NOK | 0.0% |
2019 Q3 | - NOK | 0.0% |
2019 Q4 | - NOK | 0.0% |
2019 FY | 8.76 Million NOK | 224.96% |
2018 Q2 | - NOK | 0.0% |
2018 Q1 | - NOK | 0.0% |
2018 Q4 | - NOK | 0.0% |
2018 FY | -7.01 Million NOK | 2.2% |
2018 Q3 | - NOK | 0.0% |
2017 Q3 | - NOK | 0.0% |
2017 Q2 | - NOK | 0.0% |
2017 Q1 | - NOK | 0.0% |
2017 FY | -7.17 Million NOK | 8.19% |
2017 Q4 | - NOK | 0.0% |
2016 Q2 | - NOK | 0.0% |
2016 Q1 | - NOK | 0.0% |
2016 Q3 | - NOK | 0.0% |
2016 Q4 | - NOK | 0.0% |
2016 FY | -7.81 Million NOK | -1137.18% |
2015 Q1 | - NOK | 0.0% |
2015 FY | 753 Thousand NOK | 0.0% |
2015 Q3 | - NOK | 0.0% |
2015 Q2 | - NOK | 0.0% |
2015 Q4 | - NOK | 0.0% |
2014 FY | - NOK | 0.0% |
2014 Q4 | - NOK | 0.0% |
2014 Q2 | - NOK | 0.0% |
2014 Q3 | - NOK | 0.0% |
2014 Q1 | - NOK | 0.0% |
2013 Q2 | - NOK | 0.0% |
2013 Q3 | - NOK | 0.0% |
2013 Q4 | - NOK | 0.0% |
2013 FY | - NOK | 0.0% |
2013 Q1 | - NOK | 0.0% |
2012 Q1 | - NOK | 0.0% |
2012 Q2 | - NOK | 0.0% |
2012 FY | - NOK | 0.0% |
2012 Q3 | - NOK | 0.0% |
2012 Q4 | - NOK | 0.0% |
2011 FY | - NOK | 0.0% |
2011 Q1 | - NOK | 0.0% |
2011 Q3 | - NOK | 0.0% |
2011 Q2 | - NOK | 0.0% |
2011 Q4 | - NOK | 0.0% |
2010 Q3 | - NOK | 0.0% |
2010 Q2 | - NOK | 0.0% |
2010 FY | - NOK | 0.0% |
2010 Q4 | - NOK | 0.0% |
2009 FY | - NOK | 0.0% |
2009 Q4 | - NOK | 0.0% |
2008 FY | - NOK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Arctic Bioscience AS | 32.79 Million NOK | 99.997% |
Aqua Bio Technology ASA | 5.69 Million NOK | 99.982% |
ArcticZymes Technologies ASA | 12.87 Million NOK | 99.992% |
BerGenBio ASA | 7.84 Million NOK | 99.987% |
Hofseth BioCare ASA | 82.54 Million NOK | 99.999% |
Thor Medical ASA | - NOK | -Infinity% |
Ultimovacs ASA | 1.00 NOK | -99900.0% |